AMNIPLY
Live / Registered — Registered (as of 09 Feb 2021)
What this means for you
Registered since 09 Feb 2021. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §8 declaration of use is due by 09 Feb 2027, and its filing window is open now).
Record
- Serial number
- 88877985
- Registration number
- 6264438
- Mark type
- Word mark
- Filed
- 19 Apr 2020
- Published for opposition
- 18 Aug 2020
- Registered
- 09 Feb 2021
- Next maintenance filing
- §8 declaration of use, due by 09 Feb 2027 (grace period to 09 Aug 2027)
- Attorney of record
- THOMAS L WARDEN
Goods and services
- Class 005 — Pharmaceuticals: Biological amniotic membrane tissue intended for subsequent implantation marketed for use in connection with surgical procedures and wound care
Owner
- Xiaosong Yang, Austin, TX, US
- Xiaosong Yang, Austin, TX, US
- Xiaosong Yang, Austin, TX, US
Board proceedings on this mark
- Opposition No. 91264834 — Gen-Probe Incorporated v. Xiaosong Yang, filed 16 Sept 2020 (Terminated)
Prosecution history
- 09 Feb 2026 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 09 Feb 2021 — REGISTERED-PRINCIPAL REGISTER
- 05 Jan 2021 — TTAB RELEASE CASE TO TRADEMARKS
- 05 Jan 2021 — OPPOSITION TERMINATED NO. 999999
- 05 Jan 2021 — OPPOSITION DISMISSED NO. 999999
- 16 Sept 2020 — OPPOSITION INSTITUTED NO. 999999
- 16 Sept 2020 — OPPOSITION PAPERS RECEIVED AT TTAB
- 18 Aug 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 18 Aug 2020 — PUBLISHED FOR OPPOSITION
- 29 Jul 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 Jul 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 10 Jul 2020 — ASSIGNED TO EXAMINER
- 28 Apr 2020 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 22 Apr 2020 — NEW APPLICATION ENTERED